METASTATIC PROSTATE ADENOCARCINOMA
Clinical trials for METASTATIC PROSTATE ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PROSTATE ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PROSTATE ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double-Drug attack shows promise against tough prostate cancer
Disease control OngoingThis study tests whether adding rucaparib to standard enzalutamide helps men with advanced prostate cancer that has spread and stopped responding to hormone therapy. About 61 men will receive either the combination or enzalutamide alone. The goal is to see if the combo delays can…
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated May 17, 2026 04:37 UTC
-
New drug combo aims to boost immune system against hard-to-treat prostate cancer
Disease control TerminatedThis study tests whether combining vidutolimod and nivolumab can help the immune system attack and destroy prostate cancer cells that have spread to other parts of the body. The trial includes men with metastatic castration-resistant prostate cancer who have already tried other t…
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 17, 2026 04:17 UTC
-
New drug combo shows promise for Hard-to-Treat prostate cancer
Disease control OngoingThis study tests a combination of two drugs—olaparib and radium-223—in men with castration-resistant prostate cancer that has spread to bone. Olaparib blocks a protein that helps cancer cells repair themselves, while radium-223 delivers radiation directly to bone tumors. The goal…
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Targeted attack on spreading prostate cancer shows promise
Disease control OngoingThis study is testing a two-part treatment for men whose prostate cancer has returned and spread to a few other places in the body. The treatment combines hormone-blocking drugs with very precise, high-dose radiation aimed directly at the cancer spots. The goal is to see if this …
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 20, 2026 16:15 UTC
-
Shorter radiation course tested for prostate cancer spread
Disease control OngoingThis study is testing whether a shorter, more intense course of radiation has fewer side effects for men whose prostate cancer has returned and spread to a few lymph nodes. It compares two radiation methods: proton beam therapy and standard IMRT. The main goal is to see which app…
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 20, 2026 16:14 UTC
-
Targeted drug combo tested for Tough-to-Treat prostate cancer
Disease control OngoingThis study is testing whether a combination of two drugs, niraparib/abiraterone and prednisone, can help control advanced prostate cancer that has spread and has a specific genetic mutation called SPOP. The treatment aims to stop cancer cells from repairing themselves and reduce …
Matched conditions: METASTATIC PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 13, 2026 20:19 UTC